The conglomerate was viewed as one of the most successful companies in America, but patients are enraged and investors have ...

UnitedHealth's newly returned CEO, Stephen Hemsley, will likely face investor scrutiny over the largest U.S. health insurance ...

For years UnitedHealth Group (NYSE: UNH) has normally been a reliable dividend stock. But an abysmal start to 2025 has wiped ...

UnitedHealth Group is scheduled to report second-quarter results ahead of the opening bell on Tuesday, with markets expecting ...

The healthcare sector, including managed-care firms and drug powerhouses, is vastly underperforming the S&P 500 index. Here ...

Discover key insights on UnitedHealth's (UNH) pivotal Q2 earnings call as it navigates Medicare headwinds, regulatory probes ...

Investors will be looking for a path to a turnaround from UnitedHealth’s earnings release, after an abrupt CEO change and ...

UnitedHealth faces regulatory scrutiny, fraud allegations, and leadership turmoil. Click here to learn why UNH stock is a ...

Wall Street ended higher on Friday, capping off a strong week that saw both the Nasdaq Composite and S&P 500 finish the week ...

On Thursday, the giant health care conglomerate announced that it had “proactively reached out” to the Justice Department, ...

In a filing with the Securities and Exchange Commission, UnitedHealth said it has "full confidence" in its practices. It ...

UnitedHealth Group says it is cooperating with federal criminal and civil investigations involving its market-leading ...